Oliver Kent Glass, PhD

Assistant Professor in Medicine
Assistant Professor in Pathology
Campus mail 3475 Erwin Rd., Durham, NC 27710
Phone (919) 660-6672
Email address oliver.glass@duke.edu

My research interests are understanding how and why exercise is effective in chronic disease. I am interested in the unique role of skeletal muscle as a key mediator of exercise effects. 

Education and Training

  • Ph.D., Duke University, 2015

Publications

Perlman, Adam, Susan Gould Fogerite, Oliver Glass, Elizabeth Bechard, Ather Ali, Valentine Y. Njike, Carl Pieper, et al. “Efficacy and Safety of Massage for Osteoarthritis of the Knee: a Randomized Clinical Trial..” J Gen Intern Med 34, no. 3 (March 2019): 379–86. https://doi.org/10.1007/s11606-018-4763-5.

PMID
30543021
Full Text

Glass, Oliver, Mark Dreusicke, John Evans, Elizabeth Bechard, and Ruth Q. Wolever. “Expressive writing to improve resilience to trauma: A clinical feasibility trial..” Complement Ther Clin Pract 34 (February 2019): 240–46. https://doi.org/10.1016/j.ctcp.2018.12.005.

PMID
30712734
Full Text

Glass, O. K., A. Radia, W. E. Kraus, and M. F. Abdelmalek. “Exercise training as treatment of nonalcoholic fatty liver disease.” Journal of Functional Morphology and Kinesiology 2, no. 4 (December 1, 2017). https://doi.org/10.3390/jfmk2040035.

Full Text

Glass, Oliver K., Michelle Bowie, Julie Fuller, David Darr, Jerry Usary, Keara Boss, Kingshuk Roy Choudhury, et al. “Differential response to exercise in claudin-low breast cancer..” Oncotarget 8, no. 60 (November 24, 2017): 100989–4. https://doi.org/10.18632/oncotarget.21054.

PMID
29254140
Full Text

Glass, Oliver K., Sundhar Ramalingam, and Michael R. Harrison. “Resistance exercise training in patients with genitourinary cancers to mitigate treatment-related skeletal muscle loss..” Clin Adv Hematol Oncol 14, no. 6 (June 2016): 436–46.

PMID
27379813
Scholars@Duke

Glass, O. K., B. A. Inman, G. Broadwater, K. S. Courneya, J. R. Mackey, S. Goruk, E. R. Nelson, et al. “Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study..” Br J Cancer 112, no. 5 (March 3, 2015): 825–31. https://doi.org/10.1038/bjc.2014.662.

PMID
25584487
Full Text

Glass, Oliver, Brant A. Inman, Kerry S. Courneya, John R. Mackey, Erik Nelson, Zachary Hartman, and Lee W. Jones. “Abstract 1376: Exercise alters breast cancer phenotype through distinct reductions in host-derived proinflammatory growth factor ligands..” In Clinical Research. American Association for Cancer Research, 2013. https://doi.org/10.1158/1538-7445.am2013-1376.

Full Text

Hartman, Zachary C., Junping Wei, Oliver K. Glass, Hongtao Guo, Gangjun Lei, Xiao-Yi Yang, Takuya Osada, et al. “Increasing vaccine potency through exosome antigen targeting..” Vaccine 29, no. 50 (November 21, 2011): 9361–67. https://doi.org/10.1016/j.vaccine.2011.09.133.

PMID
22001882
Full Text

Hartman, Zachary C., Xiao-Yi Yang, Oliver Glass, Gangjun Lei, Takuya Osada, Sandeep S. Dave, Michael A. Morse, Timothy M. Clay, and Herbert K. Lyerly. “HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis..” Cancer Res 71, no. 13 (July 1, 2011): 4380–91. https://doi.org/10.1158/0008-5472.CAN-11-0308.

PMID
21518778
Full Text

Hartman, Zachary C., Takuya Osada, Oliver Glass, Xiao Y. Yang, Gang-Jun Lei, H Kim Lyerly, and Timothy M. Clay. “Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity..” Cancer Res 70, no. 18 (September 15, 2010): 7209–20. https://doi.org/10.1158/0008-5472.CAN-10-0905.

PMID
20823152
Full Text

Pages